Archive | August, 2012

Scarring seen on MRI may predict ICD benefit better than assessment of LVEF

  Myocardial scarring assessed by MRI is an independent predictor of poor outcomes in implantable cardioverter defibrillator (ICD) candidates with low left ventricular ejection fraction (LVEF), new trial results show. Currently, measuring LVEF is the most common method for identifying which patients are most likely to need an implantable defibrillator to prevent sudden cardiac death, […]

Leave a comment Continue Reading →

New Recommendations on Stroke Prevention in Atrial Fibrillation

The American Heart Association (AHA)/American Stroke Association (ASA) advisory on stroke prevention in atrial fibrillation has released a new scientific advisory on use of the new oral antithrombotic agents to prevent stroke in patients with nonvalvular atrial fibrillation. The update recommends that, along with warfarin and dabigatran (Pradaxa, Boehringer Ingelheim), already recommended for this indication, […]

Leave a comment Continue Reading →